Evosep

Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster.

Business Model:

Revenue: $0

Employees: 11-50

Detailed Evosep Information

Geographic Data

Evosep headquarters map

Address: Buchwaldsgade 35

City: Odense

State: capital region

Zip: DK-5000

Country: DK

Financial Info

Stage:

series unknown

Raised Last:

$40M

Raised Total:

$40M

Metrics

1,832,408Website Global Rank

10,069Website Monthly Traffic

Twitter Followers

Description

Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster. They are targeting the growing need for throughput with robust solutions for clinical and large-scale proteomics, and they have a very ambitious business plan to bring their first products to market. They are basing their design on years of experience with nano-UHPLC R&a;D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis. Evosep aims to improve quality of life and patient care by radically innovating how protein based clinical diagnostics are performed, initially through collaborations with world-leading scientists about developing new technologies and solutions to make sample separation 10 times faster and 100 times more robust than todays’alternatives. Proteomics is about the study of proteins in a biological mechanism, both their individual function and their combined interactions. For clinical proteomics the goal is to be able to quickly and efficiently compare a biological sample against a profile panel of selected proteins in order to deliver a diagnose / verdict of healthy or diseased (within given statistical margins). Such a profile is typically called a biomarker and for official approval, it must be demonstrated successfully on a large population. This calls for fast sample processing and because such clinical samples, in the form of blood or biopsies, are much more crude that the relatively clean cell cultures used in basic research, very robust protocols and consumables are also required.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2023 Venture Round $0 Novo Holdings
Novo Holdings
6/2016 Venture Round 1 - Vaekstfonden
Vaekstfonden
1/2023 Equity 1 $40M Novo Holdings
Novo Holdings
6/2016 Venture Round 1 - Vaekstfonden
Vaekstfonden
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research